Isothermal amplification Comprehensive Study by Type (Instruments, Reagents), Application (Blood Screening, Infectious Disease Diagnosis, Other), Technology (TMA, LAMP, SDA, HDA, NASBA, Others), End User (Hospitals, Research Laboratories, Other) Players and Region - Global Market Outlook to 2030

Isothermal amplification Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Isothermal amplification
In order to study individual genes or specific DNA regions of interest, it's often necessary to obtain a large amount of nucleic acid for study. Rather than isolate one copy of the target DNA from a large number of cells, it's often additional help to get multiple copies of a target from one molecule of DNA or mRNA, via an in vitro amplification method. Isothermal amplification methods provide detection of a nucleic acid target sequence in a very efficient, exponential manner, and don't seem to be restricted by the constraint of thermal cycling. Although these methods will vary significantly, they all share some options in common. For example, because the polymer strands are not heat-denatured, all equal strategies deem an alternate approach to modify primer binding and initiation of the amplification reaction: a polymerase with strand-displacement activity. Once the reaction is initiated, the polymerase should also separate the strand that's still annealed to the sequence of interest. Isothermal amplification chemistry has been applied to diagnostics with polymerase success and is employed in many industrial molecular diagnostic platforms, serving large testing centers and point-of-care markets. Equal Amplification is turning into additional and additional standards as an easy and cost-effective alternative to standard PCR.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Isothermal amplification market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Becton, Dickinson & Company (United States), Hologic, Inc. (United States), Grifols, S.A. (Spain), EIKEN CHEMICAL CO., LTD. (Japan), Meridian Bioscience (United States), Quidel Corporation (United States), QIAGEN (Netherlands), bioMérieux SA (France), Tecan Trading AG (Switzerland), DiaSorin S.p.A. (Italy), Abbott Laboratories, Inc. (United States), Thermo Fisher Scientific, Inc. (United States), GE Healthcare (United States), Illumina, Inc. (United States), New England Biolabs, Inc. (United States), TwistDx Limited (United States), Mast Group Ltd. (United Kingdom), Lucigen Corporation (United States) and Ustar Biotechnologies Ltd. (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Genomtec SA (Poland), Jena Bioscience GmbH (Germany), OptiGene Limited (United Kingdom), Sysmex Corporation (Japan), PREMIER Biosoft (United States) and mFluiDx (United States).

Segmentation Overview
AMA Research has segmented the market of Global Isothermal amplification market by Type (Instruments and Reagents), Application (Blood Screening, Infectious Disease Diagnosis and Other) and Region.



On the basis of geography, the market of Isothermal amplification has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. TMA will boost the Isothermal amplification market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Isothermal amplification market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Adoption of The Isothermal Amplification

Market Growth Drivers:
Increase in Viral Diseases, Growing in Prevalence of Cancer, Rise in Demand for Low-cost and Effective Diagnostics Procedures and A Rise in The Miniaturization of Nucleic Acid-based Diagnostics

Challenges:
Lack of Skilled Professional and Lack of Awareness about New Diagnostics Technologies

Restraints:
High Cost of The Methods and Threatening Opposition from PCR Technologies

Opportunities:
Increasing Technological Advancements

Market Leaders and their expansionary development strategies
In 2018, Tecan, a laboratory instruments and solutions provider had acquired Nugen Technologies. The acquisition had helped Tecan for expanding into a new market segment of next-generation sequencing (NGS) reagents.
In November 2021, Meridian Bioscience, Inc, a leading global provider of diagnostic testing solutions and life science raw materials, announced the launch of its Air-Dryable LAMP Mix and Air-Dryable RT-LAMP 1-Step Mix. These ground-breaking molecular master mixes are specifically designed for fast isothermal amplification of nucleic acid sequences, not only to facilitate the development of point-of-care ambient temperature-stable assays, but also to accelerate diagnosis.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Isothermal amplification, Venture Capitalists and Private Equity Firms and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Reagents
By Application
  • Blood Screening
  • Infectious Disease Diagnosis
  • Other
By Technology
  • TMA
  • LAMP
  • SDA
  • HDA
  • NASBA
  • Others

By End User
  • Hospitals
  • Research Laboratories
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Viral Diseases
      • 3.2.2. Growing in Prevalence of Cancer
      • 3.2.3. Rise in Demand for Low-cost and Effective Diagnostics Procedures
      • 3.2.4. A Rise in The Miniaturization of Nucleic Acid-based Diagnostics
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professional
      • 3.3.2. Lack of Awareness about New Diagnostics Technologies
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of The Isothermal Amplification
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Isothermal amplification, by Type, Application, Technology, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Isothermal amplification (Value)
      • 5.2.1. Global Isothermal amplification by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents
      • 5.2.2. Global Isothermal amplification by: Application (Value)
        • 5.2.2.1. Blood Screening
        • 5.2.2.2. Infectious Disease Diagnosis
        • 5.2.2.3. Other
      • 5.2.3. Global Isothermal amplification by: Technology (Value)
        • 5.2.3.1. TMA
        • 5.2.3.2. LAMP
        • 5.2.3.3. SDA
        • 5.2.3.4. HDA
        • 5.2.3.5. NASBA
        • 5.2.3.6. Others
      • 5.2.4. Global Isothermal amplification by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Research Laboratories
        • 5.2.4.3. Other
      • 5.2.5. Global Isothermal amplification Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Isothermal amplification (Price)
      • 5.3.1. Global Isothermal amplification by: Type (Price)
  • 6. Isothermal amplification: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson & Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hologic, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Grifols, S.A. (Spain)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. EIKEN CHEMICAL CO., LTD. (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Meridian Bioscience (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Quidel Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. QIAGEN (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioMérieux SA (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tecan Trading AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. DiaSorin S.p.A. (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Abbott Laboratories, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. GE Healthcare (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Illumina, Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. New England Biolabs, Inc. (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. TwistDx Limited (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Mast Group Ltd. (United Kingdom)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. Lucigen Corporation (United States)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
      • 6.4.19. Ustar Biotechnologies Ltd. (China)
        • 6.4.19.1. Business Overview
        • 6.4.19.2. Products/Services Offerings
        • 6.4.19.3. Financial Analysis
        • 6.4.19.4. SWOT Analysis
  • 7. Global Isothermal amplification Sale, by Type, Application, Technology, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Isothermal amplification (Value)
      • 7.2.1. Global Isothermal amplification by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents
      • 7.2.2. Global Isothermal amplification by: Application (Value)
        • 7.2.2.1. Blood Screening
        • 7.2.2.2. Infectious Disease Diagnosis
        • 7.2.2.3. Other
      • 7.2.3. Global Isothermal amplification by: Technology (Value)
        • 7.2.3.1. TMA
        • 7.2.3.2. LAMP
        • 7.2.3.3. SDA
        • 7.2.3.4. HDA
        • 7.2.3.5. NASBA
        • 7.2.3.6. Others
      • 7.2.4. Global Isothermal amplification by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Research Laboratories
        • 7.2.4.3. Other
      • 7.2.5. Global Isothermal amplification Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Isothermal amplification (Price)
      • 7.3.1. Global Isothermal amplification by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Isothermal amplification: by Type(USD Million)
  • Table 2. Isothermal amplification Instruments , by Region USD Million (2018-2023)
  • Table 3. Isothermal amplification Reagents , by Region USD Million (2018-2023)
  • Table 4. Isothermal amplification: by Application(USD Million)
  • Table 5. Isothermal amplification Blood Screening , by Region USD Million (2018-2023)
  • Table 6. Isothermal amplification Infectious Disease Diagnosis , by Region USD Million (2018-2023)
  • Table 7. Isothermal amplification Other , by Region USD Million (2018-2023)
  • Table 8. Isothermal amplification: by Technology(USD Million)
  • Table 9. Isothermal amplification TMA , by Region USD Million (2018-2023)
  • Table 10. Isothermal amplification LAMP , by Region USD Million (2018-2023)
  • Table 11. Isothermal amplification SDA , by Region USD Million (2018-2023)
  • Table 12. Isothermal amplification HDA , by Region USD Million (2018-2023)
  • Table 13. Isothermal amplification NASBA , by Region USD Million (2018-2023)
  • Table 14. Isothermal amplification Others , by Region USD Million (2018-2023)
  • Table 15. Isothermal amplification: by End User(USD Million)
  • Table 16. Isothermal amplification Hospitals , by Region USD Million (2018-2023)
  • Table 17. Isothermal amplification Research Laboratories , by Region USD Million (2018-2023)
  • Table 18. Isothermal amplification Other , by Region USD Million (2018-2023)
  • Table 19. South America Isothermal amplification, by Country USD Million (2018-2023)
  • Table 20. South America Isothermal amplification, by Type USD Million (2018-2023)
  • Table 21. South America Isothermal amplification, by Application USD Million (2018-2023)
  • Table 22. South America Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 23. South America Isothermal amplification, by End User USD Million (2018-2023)
  • Table 24. Brazil Isothermal amplification, by Type USD Million (2018-2023)
  • Table 25. Brazil Isothermal amplification, by Application USD Million (2018-2023)
  • Table 26. Brazil Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 27. Brazil Isothermal amplification, by End User USD Million (2018-2023)
  • Table 28. Argentina Isothermal amplification, by Type USD Million (2018-2023)
  • Table 29. Argentina Isothermal amplification, by Application USD Million (2018-2023)
  • Table 30. Argentina Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 31. Argentina Isothermal amplification, by End User USD Million (2018-2023)
  • Table 32. Rest of South America Isothermal amplification, by Type USD Million (2018-2023)
  • Table 33. Rest of South America Isothermal amplification, by Application USD Million (2018-2023)
  • Table 34. Rest of South America Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 35. Rest of South America Isothermal amplification, by End User USD Million (2018-2023)
  • Table 36. Asia Pacific Isothermal amplification, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Isothermal amplification, by Type USD Million (2018-2023)
  • Table 38. Asia Pacific Isothermal amplification, by Application USD Million (2018-2023)
  • Table 39. Asia Pacific Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 40. Asia Pacific Isothermal amplification, by End User USD Million (2018-2023)
  • Table 41. China Isothermal amplification, by Type USD Million (2018-2023)
  • Table 42. China Isothermal amplification, by Application USD Million (2018-2023)
  • Table 43. China Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 44. China Isothermal amplification, by End User USD Million (2018-2023)
  • Table 45. Japan Isothermal amplification, by Type USD Million (2018-2023)
  • Table 46. Japan Isothermal amplification, by Application USD Million (2018-2023)
  • Table 47. Japan Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 48. Japan Isothermal amplification, by End User USD Million (2018-2023)
  • Table 49. India Isothermal amplification, by Type USD Million (2018-2023)
  • Table 50. India Isothermal amplification, by Application USD Million (2018-2023)
  • Table 51. India Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 52. India Isothermal amplification, by End User USD Million (2018-2023)
  • Table 53. South Korea Isothermal amplification, by Type USD Million (2018-2023)
  • Table 54. South Korea Isothermal amplification, by Application USD Million (2018-2023)
  • Table 55. South Korea Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 56. South Korea Isothermal amplification, by End User USD Million (2018-2023)
  • Table 57. Taiwan Isothermal amplification, by Type USD Million (2018-2023)
  • Table 58. Taiwan Isothermal amplification, by Application USD Million (2018-2023)
  • Table 59. Taiwan Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 60. Taiwan Isothermal amplification, by End User USD Million (2018-2023)
  • Table 61. Australia Isothermal amplification, by Type USD Million (2018-2023)
  • Table 62. Australia Isothermal amplification, by Application USD Million (2018-2023)
  • Table 63. Australia Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 64. Australia Isothermal amplification, by End User USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Isothermal amplification, by Type USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Isothermal amplification, by Application USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Isothermal amplification, by End User USD Million (2018-2023)
  • Table 69. Europe Isothermal amplification, by Country USD Million (2018-2023)
  • Table 70. Europe Isothermal amplification, by Type USD Million (2018-2023)
  • Table 71. Europe Isothermal amplification, by Application USD Million (2018-2023)
  • Table 72. Europe Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 73. Europe Isothermal amplification, by End User USD Million (2018-2023)
  • Table 74. Germany Isothermal amplification, by Type USD Million (2018-2023)
  • Table 75. Germany Isothermal amplification, by Application USD Million (2018-2023)
  • Table 76. Germany Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 77. Germany Isothermal amplification, by End User USD Million (2018-2023)
  • Table 78. France Isothermal amplification, by Type USD Million (2018-2023)
  • Table 79. France Isothermal amplification, by Application USD Million (2018-2023)
  • Table 80. France Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 81. France Isothermal amplification, by End User USD Million (2018-2023)
  • Table 82. Italy Isothermal amplification, by Type USD Million (2018-2023)
  • Table 83. Italy Isothermal amplification, by Application USD Million (2018-2023)
  • Table 84. Italy Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 85. Italy Isothermal amplification, by End User USD Million (2018-2023)
  • Table 86. United Kingdom Isothermal amplification, by Type USD Million (2018-2023)
  • Table 87. United Kingdom Isothermal amplification, by Application USD Million (2018-2023)
  • Table 88. United Kingdom Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 89. United Kingdom Isothermal amplification, by End User USD Million (2018-2023)
  • Table 90. Netherlands Isothermal amplification, by Type USD Million (2018-2023)
  • Table 91. Netherlands Isothermal amplification, by Application USD Million (2018-2023)
  • Table 92. Netherlands Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 93. Netherlands Isothermal amplification, by End User USD Million (2018-2023)
  • Table 94. Rest of Europe Isothermal amplification, by Type USD Million (2018-2023)
  • Table 95. Rest of Europe Isothermal amplification, by Application USD Million (2018-2023)
  • Table 96. Rest of Europe Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 97. Rest of Europe Isothermal amplification, by End User USD Million (2018-2023)
  • Table 98. MEA Isothermal amplification, by Country USD Million (2018-2023)
  • Table 99. MEA Isothermal amplification, by Type USD Million (2018-2023)
  • Table 100. MEA Isothermal amplification, by Application USD Million (2018-2023)
  • Table 101. MEA Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 102. MEA Isothermal amplification, by End User USD Million (2018-2023)
  • Table 103. Middle East Isothermal amplification, by Type USD Million (2018-2023)
  • Table 104. Middle East Isothermal amplification, by Application USD Million (2018-2023)
  • Table 105. Middle East Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 106. Middle East Isothermal amplification, by End User USD Million (2018-2023)
  • Table 107. Africa Isothermal amplification, by Type USD Million (2018-2023)
  • Table 108. Africa Isothermal amplification, by Application USD Million (2018-2023)
  • Table 109. Africa Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 110. Africa Isothermal amplification, by End User USD Million (2018-2023)
  • Table 111. North America Isothermal amplification, by Country USD Million (2018-2023)
  • Table 112. North America Isothermal amplification, by Type USD Million (2018-2023)
  • Table 113. North America Isothermal amplification, by Application USD Million (2018-2023)
  • Table 114. North America Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 115. North America Isothermal amplification, by End User USD Million (2018-2023)
  • Table 116. United States Isothermal amplification, by Type USD Million (2018-2023)
  • Table 117. United States Isothermal amplification, by Application USD Million (2018-2023)
  • Table 118. United States Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 119. United States Isothermal amplification, by End User USD Million (2018-2023)
  • Table 120. Canada Isothermal amplification, by Type USD Million (2018-2023)
  • Table 121. Canada Isothermal amplification, by Application USD Million (2018-2023)
  • Table 122. Canada Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 123. Canada Isothermal amplification, by End User USD Million (2018-2023)
  • Table 124. Mexico Isothermal amplification, by Type USD Million (2018-2023)
  • Table 125. Mexico Isothermal amplification, by Application USD Million (2018-2023)
  • Table 126. Mexico Isothermal amplification, by Technology USD Million (2018-2023)
  • Table 127. Mexico Isothermal amplification, by End User USD Million (2018-2023)
  • Table 128. Isothermal amplification: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Isothermal amplification: by Type(USD Million)
  • Table 149. Isothermal amplification Instruments , by Region USD Million (2025-2030)
  • Table 150. Isothermal amplification Reagents , by Region USD Million (2025-2030)
  • Table 151. Isothermal amplification: by Application(USD Million)
  • Table 152. Isothermal amplification Blood Screening , by Region USD Million (2025-2030)
  • Table 153. Isothermal amplification Infectious Disease Diagnosis , by Region USD Million (2025-2030)
  • Table 154. Isothermal amplification Other , by Region USD Million (2025-2030)
  • Table 155. Isothermal amplification: by Technology(USD Million)
  • Table 156. Isothermal amplification TMA , by Region USD Million (2025-2030)
  • Table 157. Isothermal amplification LAMP , by Region USD Million (2025-2030)
  • Table 158. Isothermal amplification SDA , by Region USD Million (2025-2030)
  • Table 159. Isothermal amplification HDA , by Region USD Million (2025-2030)
  • Table 160. Isothermal amplification NASBA , by Region USD Million (2025-2030)
  • Table 161. Isothermal amplification Others , by Region USD Million (2025-2030)
  • Table 162. Isothermal amplification: by End User(USD Million)
  • Table 163. Isothermal amplification Hospitals , by Region USD Million (2025-2030)
  • Table 164. Isothermal amplification Research Laboratories , by Region USD Million (2025-2030)
  • Table 165. Isothermal amplification Other , by Region USD Million (2025-2030)
  • Table 166. South America Isothermal amplification, by Country USD Million (2025-2030)
  • Table 167. South America Isothermal amplification, by Type USD Million (2025-2030)
  • Table 168. South America Isothermal amplification, by Application USD Million (2025-2030)
  • Table 169. South America Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 170. South America Isothermal amplification, by End User USD Million (2025-2030)
  • Table 171. Brazil Isothermal amplification, by Type USD Million (2025-2030)
  • Table 172. Brazil Isothermal amplification, by Application USD Million (2025-2030)
  • Table 173. Brazil Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 174. Brazil Isothermal amplification, by End User USD Million (2025-2030)
  • Table 175. Argentina Isothermal amplification, by Type USD Million (2025-2030)
  • Table 176. Argentina Isothermal amplification, by Application USD Million (2025-2030)
  • Table 177. Argentina Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 178. Argentina Isothermal amplification, by End User USD Million (2025-2030)
  • Table 179. Rest of South America Isothermal amplification, by Type USD Million (2025-2030)
  • Table 180. Rest of South America Isothermal amplification, by Application USD Million (2025-2030)
  • Table 181. Rest of South America Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 182. Rest of South America Isothermal amplification, by End User USD Million (2025-2030)
  • Table 183. Asia Pacific Isothermal amplification, by Country USD Million (2025-2030)
  • Table 184. Asia Pacific Isothermal amplification, by Type USD Million (2025-2030)
  • Table 185. Asia Pacific Isothermal amplification, by Application USD Million (2025-2030)
  • Table 186. Asia Pacific Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 187. Asia Pacific Isothermal amplification, by End User USD Million (2025-2030)
  • Table 188. China Isothermal amplification, by Type USD Million (2025-2030)
  • Table 189. China Isothermal amplification, by Application USD Million (2025-2030)
  • Table 190. China Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 191. China Isothermal amplification, by End User USD Million (2025-2030)
  • Table 192. Japan Isothermal amplification, by Type USD Million (2025-2030)
  • Table 193. Japan Isothermal amplification, by Application USD Million (2025-2030)
  • Table 194. Japan Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 195. Japan Isothermal amplification, by End User USD Million (2025-2030)
  • Table 196. India Isothermal amplification, by Type USD Million (2025-2030)
  • Table 197. India Isothermal amplification, by Application USD Million (2025-2030)
  • Table 198. India Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 199. India Isothermal amplification, by End User USD Million (2025-2030)
  • Table 200. South Korea Isothermal amplification, by Type USD Million (2025-2030)
  • Table 201. South Korea Isothermal amplification, by Application USD Million (2025-2030)
  • Table 202. South Korea Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 203. South Korea Isothermal amplification, by End User USD Million (2025-2030)
  • Table 204. Taiwan Isothermal amplification, by Type USD Million (2025-2030)
  • Table 205. Taiwan Isothermal amplification, by Application USD Million (2025-2030)
  • Table 206. Taiwan Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 207. Taiwan Isothermal amplification, by End User USD Million (2025-2030)
  • Table 208. Australia Isothermal amplification, by Type USD Million (2025-2030)
  • Table 209. Australia Isothermal amplification, by Application USD Million (2025-2030)
  • Table 210. Australia Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 211. Australia Isothermal amplification, by End User USD Million (2025-2030)
  • Table 212. Rest of Asia-Pacific Isothermal amplification, by Type USD Million (2025-2030)
  • Table 213. Rest of Asia-Pacific Isothermal amplification, by Application USD Million (2025-2030)
  • Table 214. Rest of Asia-Pacific Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 215. Rest of Asia-Pacific Isothermal amplification, by End User USD Million (2025-2030)
  • Table 216. Europe Isothermal amplification, by Country USD Million (2025-2030)
  • Table 217. Europe Isothermal amplification, by Type USD Million (2025-2030)
  • Table 218. Europe Isothermal amplification, by Application USD Million (2025-2030)
  • Table 219. Europe Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 220. Europe Isothermal amplification, by End User USD Million (2025-2030)
  • Table 221. Germany Isothermal amplification, by Type USD Million (2025-2030)
  • Table 222. Germany Isothermal amplification, by Application USD Million (2025-2030)
  • Table 223. Germany Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 224. Germany Isothermal amplification, by End User USD Million (2025-2030)
  • Table 225. France Isothermal amplification, by Type USD Million (2025-2030)
  • Table 226. France Isothermal amplification, by Application USD Million (2025-2030)
  • Table 227. France Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 228. France Isothermal amplification, by End User USD Million (2025-2030)
  • Table 229. Italy Isothermal amplification, by Type USD Million (2025-2030)
  • Table 230. Italy Isothermal amplification, by Application USD Million (2025-2030)
  • Table 231. Italy Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 232. Italy Isothermal amplification, by End User USD Million (2025-2030)
  • Table 233. United Kingdom Isothermal amplification, by Type USD Million (2025-2030)
  • Table 234. United Kingdom Isothermal amplification, by Application USD Million (2025-2030)
  • Table 235. United Kingdom Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 236. United Kingdom Isothermal amplification, by End User USD Million (2025-2030)
  • Table 237. Netherlands Isothermal amplification, by Type USD Million (2025-2030)
  • Table 238. Netherlands Isothermal amplification, by Application USD Million (2025-2030)
  • Table 239. Netherlands Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 240. Netherlands Isothermal amplification, by End User USD Million (2025-2030)
  • Table 241. Rest of Europe Isothermal amplification, by Type USD Million (2025-2030)
  • Table 242. Rest of Europe Isothermal amplification, by Application USD Million (2025-2030)
  • Table 243. Rest of Europe Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 244. Rest of Europe Isothermal amplification, by End User USD Million (2025-2030)
  • Table 245. MEA Isothermal amplification, by Country USD Million (2025-2030)
  • Table 246. MEA Isothermal amplification, by Type USD Million (2025-2030)
  • Table 247. MEA Isothermal amplification, by Application USD Million (2025-2030)
  • Table 248. MEA Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 249. MEA Isothermal amplification, by End User USD Million (2025-2030)
  • Table 250. Middle East Isothermal amplification, by Type USD Million (2025-2030)
  • Table 251. Middle East Isothermal amplification, by Application USD Million (2025-2030)
  • Table 252. Middle East Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 253. Middle East Isothermal amplification, by End User USD Million (2025-2030)
  • Table 254. Africa Isothermal amplification, by Type USD Million (2025-2030)
  • Table 255. Africa Isothermal amplification, by Application USD Million (2025-2030)
  • Table 256. Africa Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 257. Africa Isothermal amplification, by End User USD Million (2025-2030)
  • Table 258. North America Isothermal amplification, by Country USD Million (2025-2030)
  • Table 259. North America Isothermal amplification, by Type USD Million (2025-2030)
  • Table 260. North America Isothermal amplification, by Application USD Million (2025-2030)
  • Table 261. North America Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 262. North America Isothermal amplification, by End User USD Million (2025-2030)
  • Table 263. United States Isothermal amplification, by Type USD Million (2025-2030)
  • Table 264. United States Isothermal amplification, by Application USD Million (2025-2030)
  • Table 265. United States Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 266. United States Isothermal amplification, by End User USD Million (2025-2030)
  • Table 267. Canada Isothermal amplification, by Type USD Million (2025-2030)
  • Table 268. Canada Isothermal amplification, by Application USD Million (2025-2030)
  • Table 269. Canada Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 270. Canada Isothermal amplification, by End User USD Million (2025-2030)
  • Table 271. Mexico Isothermal amplification, by Type USD Million (2025-2030)
  • Table 272. Mexico Isothermal amplification, by Application USD Million (2025-2030)
  • Table 273. Mexico Isothermal amplification, by Technology USD Million (2025-2030)
  • Table 274. Mexico Isothermal amplification, by End User USD Million (2025-2030)
  • Table 275. Isothermal amplification: by Type(USD/Units)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Isothermal amplification: by Type USD Million (2018-2023)
  • Figure 5. Global Isothermal amplification: by Application USD Million (2018-2023)
  • Figure 6. Global Isothermal amplification: by Technology USD Million (2018-2023)
  • Figure 7. Global Isothermal amplification: by End User USD Million (2018-2023)
  • Figure 8. South America Isothermal amplification Share (%), by Country
  • Figure 9. Asia Pacific Isothermal amplification Share (%), by Country
  • Figure 10. Europe Isothermal amplification Share (%), by Country
  • Figure 11. MEA Isothermal amplification Share (%), by Country
  • Figure 12. North America Isothermal amplification Share (%), by Country
  • Figure 13. Global Isothermal amplification: by Type USD/Units (2018-2023)
  • Figure 14. Global Isothermal amplification share by Players 2023 (%)
  • Figure 15. Global Isothermal amplification share by Players (Top 3) 2023(%)
  • Figure 16. Global Isothermal amplification share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Becton, Dickinson & Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton, Dickinson & Company (United States) Revenue: by Geography 2023
  • Figure 20. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Hologic, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Grifols, S.A. (Spain) Revenue, Net Income and Gross profit
  • Figure 23. Grifols, S.A. (Spain) Revenue: by Geography 2023
  • Figure 24. EIKEN CHEMICAL CO., LTD. (Japan) Revenue, Net Income and Gross profit
  • Figure 25. EIKEN CHEMICAL CO., LTD. (Japan) Revenue: by Geography 2023
  • Figure 26. Meridian Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 27. Meridian Bioscience (United States) Revenue: by Geography 2023
  • Figure 28. Quidel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Quidel Corporation (United States) Revenue: by Geography 2023
  • Figure 30. QIAGEN (Netherlands) Revenue, Net Income and Gross profit
  • Figure 31. QIAGEN (Netherlands) Revenue: by Geography 2023
  • Figure 32. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 33. BioMérieux SA (France) Revenue: by Geography 2023
  • Figure 34. Tecan Trading AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Tecan Trading AG (Switzerland) Revenue: by Geography 2023
  • Figure 36. DiaSorin S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 37. DiaSorin S.p.A. (Italy) Revenue: by Geography 2023
  • Figure 38. Abbott Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Abbott Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 40. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2023
  • Figure 42. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 43. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 44. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 45. Illumina, Inc. (United States) Revenue: by Geography 2023
  • Figure 46. New England Biolabs, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 47. New England Biolabs, Inc. (United States) Revenue: by Geography 2023
  • Figure 48. TwistDx Limited (United States) Revenue, Net Income and Gross profit
  • Figure 49. TwistDx Limited (United States) Revenue: by Geography 2023
  • Figure 50. Mast Group Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 51. Mast Group Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 52. Lucigen Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 53. Lucigen Corporation (United States) Revenue: by Geography 2023
  • Figure 54. Ustar Biotechnologies Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 55. Ustar Biotechnologies Ltd. (China) Revenue: by Geography 2023
  • Figure 56. Global Isothermal amplification: by Type USD Million (2025-2030)
  • Figure 57. Global Isothermal amplification: by Application USD Million (2025-2030)
  • Figure 58. Global Isothermal amplification: by Technology USD Million (2025-2030)
  • Figure 59. Global Isothermal amplification: by End User USD Million (2025-2030)
  • Figure 60. South America Isothermal amplification Share (%), by Country
  • Figure 61. Asia Pacific Isothermal amplification Share (%), by Country
  • Figure 62. Europe Isothermal amplification Share (%), by Country
  • Figure 63. MEA Isothermal amplification Share (%), by Country
  • Figure 64. North America Isothermal amplification Share (%), by Country
  • Figure 65. Global Isothermal amplification: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson & Company (United States)
  • Hologic, Inc. (United States)
  • Grifols, S.A. (Spain)
  • EIKEN CHEMICAL CO., LTD. (Japan)
  • Meridian Bioscience (United States)
  • Quidel Corporation (United States)
  • QIAGEN (Netherlands)
  • bioMérieux SA (France)
  • Tecan Trading AG (Switzerland)
  • DiaSorin S.p.A. (Italy)
  • Abbott Laboratories, Inc. (United States)
  • Thermo Fisher Scientific, Inc. (United States)
  • GE Healthcare (United States)
  • Illumina, Inc. (United States)
  • New England Biolabs, Inc. (United States)
  • TwistDx Limited (United States)
  • Mast Group Ltd. (United Kingdom)
  • Lucigen Corporation (United States)
  • Ustar Biotechnologies Ltd. (China)
Additional players considered in the study are as follows:
Genomtec SA (Poland) , Jena Bioscience GmbH (Germany) , OptiGene Limited (United Kingdom) , Sysmex Corporation (Japan) , PREMIER Biosoft (United States) , mFluiDx (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 205 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Becton, Dickinson & Company (United States), Hologic, Inc. (United States), Grifols, S.A. (Spain), EIKEN CHEMICAL CO., LTD. (Japan), Meridian Bioscience (United States), Quidel Corporation (United States), QIAGEN (Netherlands), bioMérieux SA (France), Tecan Trading AG (Switzerland), DiaSorin S.p.A. (Italy), Abbott Laboratories, Inc. (United States), Thermo Fisher Scientific, Inc. (United States), GE Healthcare (United States), Illumina, Inc. (United States), New England Biolabs, Inc. (United States), TwistDx Limited (United States), Mast Group Ltd. (United Kingdom), Lucigen Corporation (United States) and Ustar Biotechnologies Ltd. (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Adoption of The Isothermal Amplification" is seen as one of major influencing trends for Isothermal amplification Market during projected period 2023-2030.
The Isothermal amplification market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Isothermal amplification Market Report?